FDA approves Mobius Therapeutics’ glaucoma surgery drug – The Business Journal

Mitosol provides a new way of delivering a precise dose of its active ingredient, mitomycin-c, to ophthalmic surgeons for use during glaucoma surgeries. The company will begin marketing and manufacturing the drug immediately. “The approval of …

error: Content is protected !!